Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Bioinformatics Market Potential

Vaccine Research & Development 2009

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

New Products

Advanced Wound Management Pipeline Technology and Market Forecasts to 2015

Artificial Disc Replacement Pipeline Technology and Market Forecasts to 2015

Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Brazil Orthopedic Devices Market Analysis and Forecasts to 2015

Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Canada Diabetes Care Devices Market Analysis and Forecasts to 2015

Canada Medical Equipment Market Analysis and Forecasts to 2015

Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015

China Medical Equipment Market Analysis and Forecasts to 2015

Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management

BioPortfolio | Best Practices Reports | Maintaining a Competitive Edge in Pharmaceutical Public Affairs: Benchmarking the Resources Required to Serve the U.S. Market

Maintaining a Competitive Edge in Pharmaceutical Public Affairs: Benchmarking the Resources Required to Serve the U.S. Market

To ensure organizational health and competitiveness, companies must continually identify optimal resource levels for their operations.

This benchmark study was designed to collect key staffing and investment benchmarks for U.S. based pharmaceutical Public Affairs functions.

Data from this study will allow U.S. pharmaceutical companies to assess the efficiency of their Public Affairs functions relative to their peers.

For the purposes of this benchmarking exchange, Public Affairs was divided into six work functions:

• Government Affairs (State and Federal Government Relations and Public Policy)

• Corporate Communications – External

• Corporate Communication – Internal

• Product Communications

• Corporate Social Responsibility

• Alliance Management

KEY TOPICS

• Public Affairs: Structure and Reporting Relationships

• Public Affairs: Staffing

• Public Affairs: Investment

• Public Affairs: Consolidated Staffing and Investment Efficiency Ratios

• Lessons Learned

KEY METRICS

• FTEs

• Investment Levels

• Budget per FTE

• Budget per FTE adjusted for outsourcing

• Budget as a percent of total revenue

• Budget per U.S. Brand

• Budget per U.S. Blockbuster Brand

• FTEs per U.S. Brand

• FTEs per U.S. Blockbuster Brand

• Percent of Budget Outsourced

• Public

• Public Affairs FTEs per 1,000 Total Company Employees

• Percent of Public Affairs Employees in Government Affairs

• Percent of Public Affairs Employees in Corporate Communications - External

• Percent of Public Affairs Employees in Corporate Communications - Internal

• Percent of Public Affairs Employees in Product Communications

• Percent of Public Affairs Employees in Corporate Social Responsibility

• Percent of Public Affairs Employees in Alliance Management

Industries Profiled:

Consumer Products; Diagnostic; Pharmaceutical; Biotech; Health Care

Companies Profiled:

Bayer Healthcare; MedImmune; Cephalon; Inc. ; Eli Lilly and Company; Genentech; Genzyme; GlaxoSmithKline ; Merck; Novartis; Pfizer; Roche; Sanofi-Aventis; Solvay Pharmaceuticals; UCB Pharma; Wyeth Pharmaceuticals

Keywords: Competitive, Pharmaceutical, Public Affairs, Market, Organizational Health, Resource Levels, Operations, Staffing, Investment, Government Affairs, State Government Relations, State Public Policy, Federal Government Relations, Federal Public Policy, External Corporate Communications, Internal Corporate Communications, Product Communications, Corporate Social Responsibility, Alliance Management, Public Affairs Structure, Reporting Relationships, Consolidated Staffing, Investment Efficiency Ratios, FTEs, Budget, Outsourcing, Revenue, Brand, Blockbuster, Consumer Products, Diagnostic, Biotech, Health Care, Bayer Healthcare, MedImmune, Cephalon, Eli Lilly and Company, Genentech, Genzyme, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Solvay Pharmaceuticals, UCB Pharmaceuticals, Wyeth Pharmaceuticals

Pages 48 October 2008

Price

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions